• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday

    10/4/22 3:24:21 AM ET
    $AA
    $ACOR
    $ADMP
    $ADTX
    Aluminum
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AA alert in real time by email

    Gainers

    • LogicBio Therapeutics, Inc. (NASDAQ:LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
    • FedNat Holding Company (NASDAQ:FNHC) jumped 308.7% to close at $0.47 after dipping around 28% on Friday.
    • Oblong, Inc. (NASDAQ:OBLG) gained 167% to settle at $0.40. Shares of several companies in the technology sector traded higher as stocks rebound following recent weakness.
    • FingerMotion, Inc. (NASDAQ:FNGR) shares rose 92.9% to close at $6.50 after the stock rose more than 80% Friday.
    • Wearable Devices Ltd. (NASDAQ:WLDS) gained 48.9% to close at $1.31 after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
    • Flexible Solutions International, Inc. (NYSE:FSI) gained 44.2% to close at $2.38. FSI reported termination of merger with Lygos Inc.
    • Myovant Sciences Ltd. (NYSE:MYOV) shares climbed 36.1% to close at $24.44 after the company received an acquisition offer from Sumitovant Biopharma and Sumitormo Pharma to acquire the company for $22.75 per share in cash.
    • Lottery.com Inc. (NASDAQ:LTRY) gained 34% to settle at $0.3015.
    • Blue Star Foods Corp. (NASDAQ:BSFC) jumped 32% to close at $0.8316. Blue Star Foods recently signed a one-year extension to its multi-year supply contract with Sysco Corp.
    • LiveWire Group, Inc. (NYSE:LVWR) climbed 29.5% to close at $9.30.
    • Engine Gaming and Media, Inc. (NASDAQ:GAME) gained 28.9% to close at $0.7262. Engine Gaming's Frankly Media and Aggregated Media announced a partnership.
    • Viasat, Inc. (NASDAQ:VSAT) climbed 26.9% to close at $38.37 after the company announced it entered into a definitive agreement to sell its Link 16 Tactical Data Links business to L3Harris Technologies for $1.96 billion.
    • Energy Vault Holdings, Inc. (NYSE:NRGV) surged 23.1% to settle at $6.50.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) gained 22.6% to close at $3.20.
    • Companhia de Saneamento Básico do Estado de São Paulo – SABESP (NYSE:SBS) gained 22.4% to close at $11.15.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) surged 22.2% to close at $2.15.
    • F-star Therapeutics, Inc. (NASDAQ:FSTX) rose 21.7% to settle at $6.23. F-star Therapeutics, in August, posted a Q2 loss of $0.88 per share.
    • Locafy Limited (NASDAQ:LCFY) gained 20.5% to settle at $0.47.
    • Isoray, Inc. (NYSE:ISR) jumped 20.4% to close at $0.2769. IsoRay recently announced it entered into a definitive agreement to acquire Viewpoint Molecular Targeting.
    • Century Aluminum Company (NASDAQ:CENX) gained 18.6% to close at $6.26. Shares of aluminum companies traded higher as the London Metal Exchange considers a potential ban on Russian commodities.
    • Aditxt, Inc. (NASDAQ:ADTX) climbed 18.6% to close at $4.02.
    • Athersys, Inc. (NASDAQ:ATHX) gained 18.4% to close at $2.19.
    • InterDigital, Inc. (NASDAQ:IDCC) jumped 18.3% to close at $47.81 after the company raised its Q3 sales guidance and entered into a patent license agreement with a major technology company.
    • Immunovant, Inc. (NASDAQ:IMVT) gained 18.1% to close at $6.59.
    • Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) jumped 16.7% to close at $3.84 as Brazilian President Bolsonaro outperforms polls in the Brazilian runoff election.
    • Azul S.A. (NYSE:AZUL) gained 16.3% to close at $9.47 after the Brazilian election resulted in a runoff giving Bolsonaro a chance to maintain the presidency.
    • Vertiv Holdings Co (NYSE:VRT) jumped 15.7% to close at $11.25. Vertiv Holdings Co Chief Executive Officer Rob Johnson will retire from his position due to health reasons, effective December 31, 2022.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 15.6% to close at $7.11.
    • New Gold Inc. (NYSE:NGD) gained 14.8% to close at $1.01. RBC Capital upgraded New Gold from Sector Perform to Outperform and raised the price target from $1 to $1.25.
    • BGC Partners, Inc. (NASDAQ:BGCP) rose 14.7% to close at $3.60. BGC Partners recently said it expects Q3 sales to be below the midpoint of the range it previously stated.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) rose 14.2% to close at $11.51.
    • QualTek Services Inc. (NASDAQ:QTEK) gained 13.9% to close at $2.29.
    • Coeur Mining, Inc. (NYSE:CDE) gained 13.7% to close at $3.89.
    • Endeavour Silver Corp. (NYSE:EXK) gained 13.6% to close at $3.43.
    • Oceaneering International, Inc. (NYSE:OII) jumped 12.9% to close at $8.99. Shares of oil-related stocks traded higher as oil rises amid reports suggesting OPEC+ is considering an oil production cut of 1 million barrels per day.
    • Color Star Technology Co., Ltd. (NASDAQ:CSCW) gained 12.7% to close at $1.33.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) gained 12.7% to close at $0.3370 after gaining 8% on Friday.
    • Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) rose 12.6% to close at $13.90.
    • Alcoa Corporation (NYSE:AA) gained 11.1% to close at $37.39.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) jumped 10.6% to close at $3.0963. Anebulo Pharmaceuticals recently announced interim data from the first two cohorts of Part B of its ongoing Phase 2 trial of ANEB-001 for acute cannabinoid intoxication (ACI).
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) gained 8.8% to close at $0.1850. Tenax Therapeutics, last month, said it is evaluating alternative strategic paths.
    • Mondee Holdings, Inc. (NASDAQ:MOND) gained 8.5% to close at $8.47.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) gained 8.2% to close at $3.18 after the company announced the FDA granted Fast Track designation for sapanisertib for the treatment of NRF2-mutated squamous lung cancer.
    • Kosmos Energy Ltd. (NYSE:KOS) gained 7.9% to close at $5.58. Shares of several oil stocks traded higher amid an increase in the price of oil as OPEC+ is rumored to be considering a 1M barrel per day oil production cut.
    • Mesoblast Limited (NASDAQ:MESO) gained 7.3% to close at $2.73.
    • United States Steel Corporation (NYSE:X) gained 7% to settle at $19.39.
    • Kuke Music Holding Limited (NYSE:KUKE) gained 6.2% to close at $0.50.

     

    Losers

    • Blue Apron Holdings, Inc. (NYSE:APRN) fell 45.3% to close at $3.16 on Monday after the company announced an equity distribution agreement allowing the company to sell up to $15 million of stock.
    • Clene Inc. (NASDAQ:CLNN) shares fell 28.2% to close at $2.01 after the company released topline results from the Healey ALS Platform trial of CNM-Au8, an investigational gold nanocrystal suspension, in participants with amyotrophic lateral sclerosis (ALS).
    • Nuwellis, Inc. (NASDAQ:NUWE) dipped 22.1% to settle at $0.4201 after the company announced results of the AVOID-HF clinical study analysis at the 2022 HFSA meeting, showing a "statistically superior clinical benefit of Aquadex therapy in reducing heart failure events and mortality."
    • Timber Pharmaceuticals, Inc. (NYSE:TMBR) dropped 20.9% to close at $0.0949. Timber Pharmaceuticals reported a $1.3 million registered direct offering.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 20.6% to close at $2.40. American Virtual Cloud Technologies, on Friday, announced the intent to effect a reverse stock split.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 19.5% to close at $14.59. Aura Biosciences announced interim Phase 2 data evaluating suprachoroidal administration of belzupacap sarotalocan for the first-line treatment of patients with early-stage choroidal melanoma presented at the AAO 2022.
    • Pharvaris N.V. (NASDAQ:PHVS) dropped 19.3% to close at $6.19.
    • Ecoark Holdings, Inc. (NASDAQ:ZEST) fell 19.2% to settle at $1.05.
    • GigaCloud Technology Inc. (NASDAQ:GCT) dropped 18.5% to close at $8.24. Aegis Capital initiated coverage on GigaCloud Tech with a Buy rating and announced a price target of $26.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) dropped 16.8% to close at $0.1651. Adamis Pharmaceuticals announced a review of strategic alternatives.
    • FaZe Holdings Inc. (NASDAQ:FAZE) declined 15.8% to close at $8.15.
    • SHF Holdings, Inc. (NASDAQ:SHFS) fell 14.9% to close at $5.90 after dropping 20% on Friday.
    • Eve Holding, Inc. (NYSE:EVEX) dropped 14.6% to settle at $7.89.
    • Belite Bio, Inc (NASDAQ:BLTE) fell 14% to close at $29.10. Belite Bio presented 12-month interim results of LBS-008 Phase 1b/2 study in adolescent Stargardt disease at the AAO Annual Meeting 2022.
    • Takung Art Co., Ltd. (NASDAQ:TKAT) declined 13.8% to close at $0.8970.
    • Hippo Holdings Inc. (NYSE:HIPO) fell 12.8% to close at $16.16.
    • Waldencast plc (NASDAQ:WALD) fell 12% to close at $8.80.
    • Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) fell 10.6% to close at $61.04.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) fell 10.6% to close at $7.86.
    • Third Harmonic Bio, Inc. (NASDAQ:THRD) dropped 10.4% to close at $17.00.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) fell 10.3% to close at $0.0969. Maxim Group recently downgraded Kintara Therapeutics from Buy to Hold.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 10% to close at $2.44.
    • mCloud Technologies Corp. (NASDAQ:MCLD) dipped 9.3% to settle at $1.36.
    • Lilium N.V. (NASDAQ:LILM) dropped 9.2% to close at $2.07. Lilium recently announced partnership with GlobeAir.
    • Tesla, Inc. (NASDAQ:TSLA) shares fell 8.6% to close at $242.40 after the company reported third-quarter vehicle deliveries below Wall Street expectations. Tesla said it produced 365,923 vehicles in the quarter and delivered 343,830.
    • Lordstown Motors Corp. (NASDAQ:RIDE) dropped 7.7% to settle at $1.69.
    • Remitly Global, Inc. (NASDAQ:RELY) fell 6.1% to close at $10.44.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ACOR
    $ADMP
    $ADTX

    CompanyDatePrice TargetRatingAnalyst
    Coeur Mining Inc.
    $CDE
    2/20/2026Buy → Hold
    Canaccord Genuity
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tyra Biosciences Inc.
    $TYRA
    2/10/2026Outperform
    William Blair
    Remitly Global Inc.
    $RELY
    2/10/2026$18.00Buy
    BofA Securities
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Remitly Global Inc.
    $RELY
    1/27/2026$17.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AA
    $ACOR
    $ADMP
    $ADTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Zeltser Guy bought $4,808 worth of shares (665 units at $7.23) and covered exercise/tax liability with 4,483 shares, decreasing direct ownership by 6% to 65,042 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/18/26 7:02:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AA
    $ACOR
    $ADMP
    $ADTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Coeur Mining downgraded by Canaccord Genuity

    Canaccord Genuity downgraded Coeur Mining from Buy to Hold

    2/20/26 8:21:45 AM ET
    $CDE
    Precious Metals
    Basic Materials

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    William Blair initiated coverage on Tyra Biosciences

    William Blair initiated coverage of Tyra Biosciences with a rating of Outperform

    2/10/26 8:03:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ACOR
    $ADMP
    $ADTX
    SEC Filings

    View All

    ContextLogic Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ContextLogic Holdings Inc. (0002064307) (Filer)

    2/23/26 5:16:49 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form FWP filed by Vertiv Holdings LLC

    FWP - Vertiv Holdings Co (0001674101) (Subject)

    2/23/26 5:04:48 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form DEF 14C filed by Blue Star Foods Corp.

    DEF 14C - Blue Star Foods Corp. (0001730773) (Filer)

    2/23/26 4:51:03 PM ET
    $BSFC

    $AA
    $ACOR
    $ADMP
    $ADTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium

    CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that two abstracts have been accepted for presentation at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (ASCO GU). The meeting is being held February 26-28, 2026, in San Francisco, California.Details of the poster presentations are below:Title: "ctDNA monitoring of FGFR3-altered metastatic urothelial cancer treated with dabogratinib (formerly TYRA-300) in the SURF301 trial"Abstract Number: 809Session: Poste

    2/23/26 5:30:00 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Remitly Announces Upcoming Webinar and Investor Conference Participation

    SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences: Post-Earnings Webinar with JP MorganDate: Tuesday, February 24, 2026Time: 11 a.m. Eastern Time / 8 a.m. Pacific Time Baird Silicon Slopes Technology SummitDate: Thursday, February 26, 2026 Morgan Stanley Technology, Media & Telecom ConferenceDate: Monday, March 2, 2026 The Citizens Technology ConferenceDate: Tuesday, March 3, 2026Time: 4:00 p.m. Eastern Time / 1:00 p.m. Pacific Time Citadel Securities SMID-Cap ConferenceDate: Thursday, Marc

    2/23/26 4:05:00 PM ET
    $RELY
    Real Estate

    Century Aluminum to Participate in BMO 2026 Global Metals, Mining & Critical Minerals Conference

    CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) today announced that Jesse Gary, Century's President and Chief Executive Officer, will present and participate in a question-and-answer session at the BMO Global Metals, Mining, & Critical Minerals Conference, beginning at approximately 8:15 a.m. EST on Tuesday, February 24, 2026. A real-time audio webcast of this session will be available on the "Investors" section of Century's website www.centuryaluminum.com. About Century Aluminum CompanyWith its corporate headquarters located in Chicago, IL, Century Aluminum owns and operates primary aluminum smelting facilities in the United States and Iceland and is t

    2/23/26 9:21:10 AM ET
    $CENX
    Aluminum
    Industrials

    $AA
    $ACOR
    $ADMP
    $ADTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ACOR
    $ADMP
    $ADTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gunningham Sebastian J was granted 787,500 shares (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    2/23/26 6:46:43 PM ET
    $RELY
    Real Estate

    SEC Form 3 filed by new insider Gunningham Sebastian J

    3 - Remitly Global, Inc. (0001782170) (Issuer)

    2/23/26 6:45:22 PM ET
    $RELY
    Real Estate

    Director Das Paramita was granted 5,247 shares, increasing direct ownership by 7% to 82,167 units (SEC Form 4)

    4 - Coeur Mining, Inc. (0000215466) (Issuer)

    2/23/26 5:29:18 PM ET
    $CDE
    Precious Metals
    Basic Materials

    $AA
    $ACOR
    $ADMP
    $ADTX
    Leadership Updates

    Live Leadership Updates

    View All

    Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer

    SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company") today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer ("CEO") and member of the Board of Directors (the "Board"), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth that built Remitly into one of the world's leading networks for digital and physical money movement. Mr. Oppenheimer will continue to serve as Chairman of the Board. Sebastian Gunningham brings decades of global leadership and product innovation exp

    2/18/26 4:05:00 PM ET
    $RELY
    Real Estate

    Remitly Reports Fourth Quarter and Full Year 2025 Results Above Outlook

    Reported first full year of GAAP profitabilityRecord fourth quarter results: revenue of $442.2 million, net income of $41.2 million, and Adjusted EBITDA of $88.6 million SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of financial services that transcend borders, reported results for the fourth quarter and full year ended December 31, 2025. "We ended 2025 with very strong results, exceeding our guidance for both revenue and Adjusted EBITDA," said Matt Oppenheimer, co-founder and Chief Executive Officer, Remitly. "These exceptional results and the strategic accomplishments realized in 2025 create the right moment to accelerate execution wi

    2/18/26 4:04:00 PM ET
    $RELY
    Real Estate

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AA
    $ACOR
    $ADMP
    $ADTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    12/6/24 9:30:49 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    $AA
    $ACOR
    $ADMP
    $ADTX
    Financials

    Live finance-specific insights

    View All

    Century Aluminum Company Reports Fourth Quarter 2025 Results

    CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) today announced its fourth quarter and full year 2025 results. Fourth Quarter 2025 Highlights Net sales of $633.7 millionReported net income attributable to Century stockholders of $1.8 million, or $0.02 per diluted share; Adjusted net income attributable to Century stockholders of $128.2 million1, or $1.25 per share; Adjusted EBITDA attributable to Century stockholders of $170.6 million1Ending cash and cash equivalents of $134.2 million and strong liquidity of $418.0 million at December 31, 2025 Full Year 2025 Highlights Net sales of $2.5 billionReported net income attributable to Century stockholders of

    2/19/26 4:05:00 PM ET
    $CENX
    Aluminum
    Industrials

    Oceaneering Reports Fourth Quarter and Full Year 2025 Results

    Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) today reported fourth quarter and full year 2025 results. Fourth Quarter 2025 Results As compared to the fourth quarter of 2024: Revenue was $669 million, a decrease of 6%. Operating income was $65.4 million, a decrease of 16%. Net income was $178 million, an increase of 217%, which included a discrete tax benefit due to the release of valuation allowances for deferred tax assets. Adjusted EBITDA was $90.5 million, a decrease of 11%. Cash Flow and Share Repurchases Cash flow provided by operating activities was $221 million. Free cash flow was $191 million. Shares repurchased were 419,005 for approximat

    2/18/26 5:01:00 PM ET
    $OII
    Oilfield Services/Equipment
    Energy

    Coeur Reports Fourth Quarter and Full-Year 2025 Results

    2025 revenue nearly doubles to $2.1 billion on record production and prices; net income increases more than tenfold to $586 million and adjusted EBITDA more than triples to $1 billion; provides 2026 guidance reflecting expected record results Coeur Mining, Inc. ("Coeur" or the "Company") (NYSE:CDE) today reported record fourth quarter 2025 financial results, including revenue of $675 million and cash flow from operating activities of $375 million. The Company reported record quarterly GAAP net income from continuing operations of $215 million, or $0.29 per share. On an adjusted basis1, Coeur reported record quarterly EBITDA of $425 million, record cash flow from operating activities befor

    2/18/26 4:30:00 PM ET
    $CDE
    Precious Metals
    Basic Materials